Ladenburg Thalmann Financial Services’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $10K | Hold |
3,169
| – | – | ﹤0.01% | 4509 |
|
|
2019
Q3 | $6K | Buy |
3,169
+8
| +0.3% | +$15 | ﹤0.01% | 4657 |
|
|
2019
Q2 | $9K | Sell |
3,161
-14,964
| -83% | -$42.6K | ﹤0.01% | 4508 |
|
|
2019
Q1 | $67K | Hold |
18,125
| – | – | ﹤0.01% | 3201 |
|
|
2018
Q4 | $52K | Sell |
18,125
-1,017
| -5% | -$2.92K | ﹤0.01% | 3223 |
|
|
2018
Q3 | $50K | Sell |
19,142
-5,000
| -21% | -$13.1K | ﹤0.01% | 3320 |
|
|
2018
Q2 | $71K | Hold |
24,142
| – | – | ﹤0.01% | 3017 |
|
|
2018
Q1 | $71K | Buy |
24,142
+3,125
| +15% | +$9.19K | ﹤0.01% | 3017 |
|
|
2017
Q4 | $58K | Hold |
21,017
| – | – | ﹤0.01% | 3128 |
|
|
2017
Q3 | $71K | Hold |
21,017
| – | – | ﹤0.01% | 2838 |
|
|
2017
Q2 | $52K | Hold |
21,017
| – | – | ﹤0.01% | 3004 |
|
|
2017
Q1 | $48K | Buy |
21,017
+19,547
| +1,330% | +$44.6K | ﹤0.01% | 2952 |
|
|
2016
Q4 | $3K | Sell |
1,470
-10,700
| -88% | -$21.8K | ﹤0.01% | 4495 |
|
|
2016
Q3 | $41K | Sell |
12,170
-443
| -4% | -$1.49K | ﹤0.01% | 2951 |
|
|
2016
Q2 | $40K | Buy |
12,613
+744
| +6% | +$2.36K | ﹤0.01% | 2865 |
|
|
2016
Q1 | $40K | Sell |
11,869
-5,406
| -31% | -$18.2K | ﹤0.01% | 2761 |
|
|
2015
Q4 | $61K | Sell |
17,275
-2,808
| -14% | -$9.92K | ﹤0.01% | 2424 |
|
|
2015
Q3 | $101K | Buy |
20,083
+1,127
| +6% | +$5.67K | ﹤0.01% | 1983 |
|
|
2015
Q2 | $121K | Buy |
18,956
+22
| +0.1% | +$140 | ﹤0.01% | 1965 |
|
|
2015
Q1 | $132K | Buy |
18,934
+1,539
| +9% | +$10.7K | ﹤0.01% | 1883 |
|
|
2014
Q4 | $134K | Buy |
17,395
+5,446
| +46% | +$42K | ﹤0.01% | 1697 |
|
|
2014
Q3 | $89K | Buy |
11,949
+857
| +8% | +$6.38K | ﹤0.01% | 1671 |
|
|
2014
Q2 | $107K | Sell |
11,092
-1,944
| -15% | -$18.8K | ﹤0.01% | 1566 |
|
|
2014
Q1 | $108K | Sell |
13,036
-1,080
| -8% | -$8.95K | ﹤0.01% | 1473 |
|
|
2013
Q4 | $119K | Sell |
14,116
-1,454
| -9% | -$12.3K | ﹤0.01% | 1359 |
|
|
2013
Q3 | $125K | Sell |
15,570
-153
| -1% | -$1.23K | ﹤0.01% | 1265 |
|
|
2013
Q2 | $122K | Buy |
+15,723
| New | +$122K | ﹤0.01% | 1215 |
|